PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 10 months ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 1 year 11 months ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
BRIEF published on 11/06/2024 at 07:35, 1 year 11 months ago Sensorion participera aux principales conférences d'investisseurs en novembre 2024 Biotechnologie Conférences D'investisseurs Sensorion Thérapies Pour La Perte Auditive Développement De La Thérapie Génique
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 11 months ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 11 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs en novembre 2024. Découvrez les événements à venir et les programmes de thérapie de l'entreprise Biotechnologie Conférences Investisseurs Événements Sensorion Thérapies Auditives
BRIEF published on 09/20/2024 at 07:35, 2 years 1 month ago Sensorion dévoile de nouvelles avancées cliniques prometteuses Biotechnologie Essais Cliniques Thérapie Génique Perte Auditive Petite Molécule
BRIEF published on 09/20/2024 at 07:35, 2 years 1 month ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 2 years 1 month ago Informations privilégiées / Autres communiqués Sensorion annonce de nouvelles données cliniques positives lors du Congrès Mondial d'Audiologie à Paris concernant les programmes de thérapie génique et de petite molécule Thérapie Génique Sensorion Données Cliniques Petite Molécule Congrès Mondial D'Audiologie
PRESS RELEASE published on 09/20/2024 at 07:30, 2 years 1 month ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
BRIEF published on 09/18/2024 at 07:35, 2 years 1 month ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
Published on 10/26/2026 at 13:30, 5 hours 3 minutes ago Stabilis Solutions Announces Third Quarter 2026 Conference Call and Webcast Date
Published on 10/26/2026 at 13:00, 5 hours 33 minutes ago BTU Commences Initial Drill Program on Hubcap Project Adjacent to RPX in Wawa
Published on 10/26/2026 at 12:30, 6 hours 3 minutes ago Longview Capital Announces Voluntary TSXV Delisting
Published on 10/26/2026 at 17:59, 34 minutes ago EQS-Adhoc: CANCOM SE publishes preliminary Q3 2026 figures and revises its revenue forecast for the 2026 financial year
Published on 10/26/2026 at 17:52, 40 minutes ago Viromed Medical AG: Successful Completion of Capital Increase
Published on 10/26/2026 at 17:48, 45 minutes ago Original-Research: FRIWO AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 10/26/2026 at 17:40, 53 minutes ago VALBIOTIS SA: Valbiotis ouvre un nouveau relais de croissance avec la commercialisation de l’ensemble de ses gammes sur Amazon France
Published on 10/26/2026 at 18:11, 22 minutes ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 22 minutes ago Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 48 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.
